[Infection during cirrhosis].
Grange
Jean-Didier
JD
Hépato-Gastroentérologie, Hôpital Tenon, 4 rue de la Chine, 75020 Paris. jean-didier.grange@tnn.ap-hop-paris.fr
D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D001201:Ascites / Q000150:complications*; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000628:therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D009643:Norfloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002443:Ceftriaxone; D000658:Amoxicillin; D009643:Norfloxacin